Patent · US Active

Anti-VEGF antibodies

US8512699B2 · kind B2 · utility

21Cited by
26References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2010
Grant dateAug 20, 2013
Priority date
Expiry dateJun 15, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Anti-VEGF antibodies and variants thereof, including those having high affinity for binding to VEGF, are disclosed. Also provided are methods of using phage display technology with naïve libraries to generate and select the anti-VEGF antibodies with desired binding and other biological activities. Further contemplated are uses of the antibodies in research, diagnostic and therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.